Navigation Links
Fluorescence Polarization (Fetal Lung Maturity)

ProductsFluorescence Polarization (Fetal Lung Maturity)
Company ARUP Laboratories
Item Fluorescence Polarization (Fetal Lung Maturity)
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Total Internal Reflection Fluorescence Microscopy
2. Epi-Fluorescence Module
3. M Bio Fluorescence Microscope
4. TIRF (Total Internal Reflection Fluorescence)
5. FLx800 Microplate Fluorescence Reader
6. DNA Engine Opticon Continuous Fluorescence Detection System
7. DNA Engine Opticon 2 Continuous Fluorescence Detection System
8. RF-1501 Fluorescence Spectrophotometer
9. Cargille Microscope Immersion Oils - Fluorescence Microscopy Immersion Oils
10. Factor V Leiden by PCR & Fluorescence Monitoring
11. HLA-B27 by PCR & Fluorescence Monitoring
The ThermaViewer™ is constructed and engineered for use in laboratories, hospitals, and commercial kitchens to monitor and document freezer and refrigerator temperatures where inventory is store
Sponge style scrub brush and nail cleaner is impregnated for antimicrobial cleaning.
HIBICLENS' non-drying, low skin irritation potential promotes compliance with the frequent hand washing associated with today's clinical protocols.
BioSoft alcohol gel hand antiseptic with soothing moisturizers is a fast-acting, broad-spectrum antimicrobial solution. BioSoft alcohol gel hand antiseptic applies easily, requires no rinsing and dri
Medicine Products:
(Date:5/16/2008)...ESTER, Minn., May 16 /PRNewswire-USNewswire/ -- Th... by Mayo Clinic in conjunction with the,National C...w study being presented at the American Society of...020), may change treatment practice,in about 25 pe...is for,proposed changes to the way colorectal canc...
(Date:5/16/2008)...study being presented at the American Society of C...0), may change treatment practice in about 25 perc... for proposed changes to the way colorectal cancer...onal Cancer Institute (NCI) SEER population-based ...III clinical trial data, shows that outcomes of pa...
(Date:5/16/2008)...ngton) Declaring that Primary care medicine is in...resident of the American College of Physicians (AC...employers and consumers to issue a call for compre...eral internists and other primary care physicians....imary care medicine in the U.S., Dr. Dale and othe...
(Date:5/16/2008)...e to Save Vital Services for Frail Seniors and Peo...RNewswire-USNewswire/ -- Thousands of,homecare wor...Schwarzenegger,s proposed cuts to hours of service...lifornia,s most vulnerable workers and the,people ...ve these vital,services for seniors and people wit...
Breaking Medicine News(10 mins):Health News:New Method Proposed for Determining Which Patients Should Get Treatment for Colorectal Cancer 2Health News:ACP says major system reforms needed to improve the state of primary care medicine in the US 2Health News:Homecare Workers Outraged by Proposed Cuts, Wage Reductions 2
... for her upcoming tour bosses have asked her to si...e gig is over . According to a source, although t...y soon, she was bugged by the contract as no other...to sign such contract. Its just a practical requi...
...ks about her, claiming that the actress is too old...tcher tied the knot in September 2005, and the act...y. Lesley Guynes, who is separated from Moores ha...at the 44-year-old actress was unable to have kids...
...for not turning up on time and lying to her . The...her about visiting her dad in Wales, while she was...d to take care of her son Harvey as the nanny did ...layed for Radio One show, for which she was critic...
...harged with two felony counts of possession of a c...ssion of a controlled substance without a prescrip...infraction in connection with the pull over of his...ent source revealed on Friday that 140 Vicodin pil...
Other Medicine News:
(Date:5/15/2008)... with a newly cleared device to identify the, lip...are associated with complication... /- InfraReDx, Inc. today,announced t...Mich., have,successfully used its LipiScan(TM) Cor...diac catheterization. This is the first patient in...
(Date:5/15/2008)...e/ -- CenterWatch, a publishing and,information se...inical,trials, finds that investigative sites are ...pture) systems. More than 75% of respondents to a ...been trained on three or more,EDC systems. In addi...of,their EDC training had improved., State of the...
(Date:5/15/2008)...ins for an Antiplatelet Therapy that, Combined, wi...ion of Plavix/Iscover and Aspirin, According t...Mass., May 15 /- Decision Resources, ...irms for pharmaceutical and,healthcare issues, fin...improvement in patient compared to Sanofi-Aventis/...
(Date:5/15/2008)... Study Compares Genous, Boston Scientific,s ...ions Focus on Real-World Use of Genous, Stent,s Pe...ot Tolerate Dual-Antiplatelet ...ewswire/ -- OrbusNeich today announced,that multip...uroPCR 2008,support the use of the company,s Genou...
Breaking Medicine Technology:First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 2Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 3Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 4Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights 5002 1Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights 5002 2Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights 5002 3Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights 5002 4Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights 5002 5Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights 5002 6Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights 5002 7Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights 5002 8Cadence Pharmaceuticals CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May 2008 4998 1Cadence Pharmaceuticals CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May 2008 4998 2Genetic Changes May Dictate Course of Acute Myeloid Leukemia 18089 1Genetic Changes May Dictate Course of Acute Myeloid Leukemia 18089 2Genetic Changes May Dictate Course of Acute Myeloid Leukemia 18089 3EAU Technologies to Present at AeA Micro Cap Conference 18087 1EAU Technologies to Present at AeA Micro Cap Conference 18087 2EAU Technologies to Present at AeA Micro Cap Conference 18087 3
..., April 17, 2007 /PRNewswire/ - OncoGenex Technolo...nical trial of OGX-011,in combination with docetax.... Data was presented by the National Cancer Instit...can Association for,Cancer Research 2007 Annual Me...concluded:, - Of the 15 patients treated,...
...neration,pyridopyrazine-urea derivative compound...ich could be valuable for cancer,treatment , ...ntaris Inc. (TSX: AEZ; Nasdaq:,AEZS), a global, ...ndocrine therapy and oncology, today presented an ...ridopyrazine derivatives,with high selectivity f...
Other Medicine Technology:OncoGenex Technologies Announces Phase II Data of OGX-011 in,Metastatic Breast Cancer at American Association for Cancer,Research 2007 Annual Meeting 2OncoGenex Technologies Announces Phase II Data of OGX-011 in,Metastatic Breast Cancer at American Association for Cancer,Research 2007 Annual Meeting 3OncoGenex Technologies Announces Phase II Data of OGX-011 in,Metastatic Breast Cancer at American Association for Cancer,Research 2007 Annual Meeting 4terna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 2terna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 3terna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 4